Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001662002-18-000002
Filing Date
2018-05-16
Accepted
2018-05-16 12:41:22
Documents
1
Effectiveness Date
2018-05-16
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10649
  Complete submission text file 0001662002-18-000002.txt   11729
Mailing Address 1600 FAIRVIEW AVE E. SUITE 100 SUITE 202 SEATTLE WA 98102
Business Address 1600 FAIRVIEW AVE E. SUITE 100 SUITE 202 SEATTLE WA 98102 206-519-5300
Nohla Therapeutics Inc. (Filer) CIK: 0001662002 (see all company filings)

EIN.: 475261773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-312535 | Film No.: 18839420